Addicks GC, Rowan-Carroll A, Reardon AJF, Leingartner K, Williams A, Meier MJ, Moffat I, Carrier R, Lorusso L, Wetmore BA, Yauk CL, Atlas E (2023) Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids. Toxicol Sci 194(1):38–52. https://doi.org/10.1093/toxsci/kfad044
Article CAS PubMed PubMed Central Google Scholar
Adeleye Y, Andersen M, Clewell R et al (2015) Implementing toxicity testing in the 21st century (TT21C): making safety decisions using toxicity pathways, and progress in a prototype risk assessment. Toxicology 332:102–111. https://doi.org/10.1016/j.tox.2014.02.007
Article CAS PubMed Google Scholar
Adeva-Andany MM, Carneiro-Freire N, Seco-Filgueira M et al (2019) Mitochondrial β-oxidation of saturated fatty acids in humans. Mitochondrion 46:73–90. https://doi.org/10.1016/j.mito.2018.02.009
Article CAS PubMed Google Scholar
Aguayo-Orozco A, Bois FY, Brunak S, Taboureau O (2018) Analysis of time-series gene expression data to explore mechanisms of chemical-induced hepatic steatosis toxicity. Front Genet 9:396. https://doi.org/10.3389/fgene.2018.00396
Article CAS PubMed PubMed Central Google Scholar
Ahowesso C, Black PN, Saini N, Montefusco D, Chekal J, Malosh C, Lindsley CW, Stauffer SR, DiRusso CC (2015) Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death. Biochem Pharmacol 98(1):167–181. https://doi.org/10.1016/j.bcp.2015.09.004
Article CAS PubMed PubMed Central Google Scholar
Aires CCP, IJlst L, Stet F et al (2010) Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem Pharmacol 79:792–799. https://doi.org/10.1016/j.bcp.2009.10.011
Article CAS PubMed Google Scholar
Alarcan J, de Sousa G, Katsanou ES et al (2022) Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach. Arch Toxicol 96:211–229. https://doi.org/10.1007/s00204-021-03182-1
Article CAS PubMed Google Scholar
Albrecht W, Kappenberg F, Brecklinghaus T et al (2019) Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch Toxicol 93:1609–1637. https://doi.org/10.1007/s00204-019-02492-9
Article CAS PubMed Google Scholar
Aldana J, Romero-Otero A, Cala MP (2020) Exploring the lipidome: current lipid extraction techniques for mass spectrometry analysis. Metabolites 10:231. https://doi.org/10.3390/metabo10060231
Article CAS PubMed PubMed Central Google Scholar
Al-Eryani L, Wahlang B, Falkner KC et al (2015) Identification of environmental chemicals associated with the development of toxicant associated fatty liver disease in rodents. Toxicol Pathol 43:482–497. https://doi.org/10.1177/0192623314549960
Article CAS PubMed Google Scholar
Allard J, Bucher S, Massart J, Ferron P-J, Le Guillou D, Loyant R, Daniel Y, Launay Y, Buron N, Begriche K, Borgne-Sanchez A, Fromenty B (2021) Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol 37(2):151–175. https://doi.org/10.1007/s10565-020-09537-1
Article CAS PubMed Google Scholar
Amacher DE (2011) The mechanistic basis for the induction of hepatic steatosis by xenobiotics. Expert Opin Drug Metab Toxicol 7:949–965. https://doi.org/10.1517/17425255.2011.577740
Article CAS PubMed Google Scholar
Amacher D, Chalasani N (2014) Drug-induced hepatic steatosis. Semin Liver Dis 34:205–214. https://doi.org/10.1055/s-0034-1375960
Article CAS PubMed Google Scholar
Angrish MM, Mets BD, Jones AD, Zacharewski TR (2012) Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice. Toxicol Sci 128:377–386. https://doi.org/10.1093/toxsci/kfs155
Article CAS PubMed PubMed Central Google Scholar
Angrish MM, McQueen CA, Cohen-Hubal E et al (2017) Mechanistic toxicity tests based on an adverse outcome pathway network for hepatic steatosis. Toxicol Sci off J Soc Toxicol 159:159–169. https://doi.org/10.1093/toxsci/kfx121
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730–741. https://doi.org/10.1002/etc.34
Article CAS PubMed Google Scholar
Anthérieu S, Rogue A, Fromenty B, Guillouzo A, Robin M-A (2011) Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells. Hepatology 53(6):1895–1905. https://doi.org/10.1002/hep.24290
Article CAS PubMed Google Scholar
Appelqvist H, Stranius K, Börjesson K, Nilsson KPR, Dyrager C (2017) Specific imaging of intracellular lipid droplets using a benzothiadiazole derivative with solvatochromic properties. Bioconjug Chem 28(5):1363–1370. https://doi.org/10.1021/acs.bioconjchem.7b00048
Article CAS PubMed Google Scholar
Arciello M, Gori M, Maggio R, Barbaro B, Tarocchi M, Galli A, Balsano C (2013) Environmental pollution: a tangible risk for NAFLD pathogenesis. Int J Mol Sci 14(11):22052–22066. https://doi.org/10.3390/ijms141122052
Article CAS PubMed PubMed Central Google Scholar
Armstrong LE, Guo GL (2019) Understanding environmental contaminants’ direct effects on non-alcoholic fatty liver disease progression. Curr Environ Health Rep 6:95–104. https://doi.org/10.1007/s40572-019-00231-x
Article PubMed PubMed Central Google Scholar
Arnesdotter E, Spinu N, Firman J, Ebbrell D, Cronin MTD, Vanhaecke T, Vinken M (2021) Derivation, characterisation and analysis of an adverse outcome pathway network for human hepatotoxicity. Toxicology 459:152856. https://doi.org/10.1016/j.tox.2021.152856
Article CAS PubMed Google Scholar
Ates G, Vanhaecke T, Rogiers V, Rodrigues RM (2017) Assaying cellular viability using the neutral red uptake assay. In: Gilbert DF, Friedrich O (eds) Cell viability assays: methods and protocols. Springer, New York, New York, NY, pp 19–26
Bai X, Hong W, Cai P, Chen Y, Xu C, Cao Di, Yu W, Zhao Z, Huang M, Jin J (2017) Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol 324:12–25. https://doi.org/10.1016/j.taap.2017.03.022
Article CAS PubMed Google Scholar
Bajard L, Melymuk L, Blaha L (2019) Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and adverse outcome pathways. Environ Sci Eur 31:14. https://doi.org/10.1186/s12302-019-0195-z
Ball N, Bars R, Botham PA et al (2022) A framework for chemical safety assessment incorporating new approach methodologies within REACH. Arch Toxicol 96:743–766. https://doi.org/10.1007/s00204-021-03215-9
Article CAS PubMed PubMed Central Google Scholar
Bal-Price A (2018) Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. ALTEX 306–352. https://doi.org/10.14573/altex.1712081
Basak S, Murmu A, Matore BW, Roy PP, Singh J (2024) Thiazolidinedione an auspicious scaffold as PPAR-γ agonist: its possible mechanism to manoeuvre against insulin resistant diabetes mellitus. Eur J Med Chem Rep 11:100160. https://doi.org/10.1016/j.ejmcr.2024.100160
Batchuluun B, Pinkosky SL, Steinberg GR (2022) Lipogenesis inhibitors: therapeutic opportunities and challenges. Nat Rev Drug Discov 21:283–305. https://doi.org/10.1038/s41573-021-00367-2
Comments (0)